openPR Logo
Press release

Datavault AI (NASDAQ: DVLT) Powers Scilex Holding (NASDAQ: SCLX) with Exclusive License to Tokenize $2 Trillion in Biotech - Bonus Stocks Inside

11-04-2025 06:46 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: ABNewswire

Datavault AI (NASDAQ: DVLT) Powers Scilex Holding (NASDAQ:

Datavault AI Inc. (NASDAQ: DVLT) has entered into a groundbreaking agreement with Scilex Holding Company (NASDAQ: SCLX), granting Scilex a worldwide exclusive license-with rights to sublicense-its proprietary AI-driven data tokenization technology for the biotech and biopharma industries.

This agreement marks a defining moment for Datavault AI (DVLT), whose patented "Platform and Method for Tokenizing DNA Data" (U.S. Patent Application No. 17/941,623) establishes a secure framework for converting sensitive genomic and therapeutic data into tradable digital assets. The technology underpins the creation of a Biotech Exchange Platform, enabling tokenization, trading, and monetization of genomic, diagnostic, and pharmaceutical intellectual property-paving the way for a new financial layer within the life sciences sector.

Breaking News Bonus: Watch these Undervalued Companies with major news today: Roadzen Inc. (NASDAQ: RDZN), Power Metallic Mines Inc. (OTCQB: PNPNF | TSXV: PNPN), Datavault AI Inc. (Nasdaq: DVLT), Peraso Inc (NASDAQ: PRSO), Kartoon Studios, Inc (NASDAQ: TOON), Specificity Inc. (OTCID: SPTY ), Intelligent Bio Solutions Inc. (NASDAQ: INBS) and Scilex Holding Company (NASDAQ: SCLX) are moving actively in pre-market and early trading sessions. Also stay alert as this is short squeeze season and our scanners indicate "shorting" in ALL of these stocks previous from today.

Scilex Holding Company (SCLX), a revenue-generating innovator in non-opioid pain management and emerging therapeutic solutions, will integrate DVLT's platform to launch a next-generation data marketplace. The platform aims to unlock an estimated $2 trillion opportunity across global pharmaceutical and diagnostic sales through the tokenization of real-world biotech assets (RWAs).

Beyond data security, the collaboration opens the door for non-dilutive funding mechanisms-allowing biotech and pharma companies to raise capital by tokenizing intellectual property, research data, and therapeutic innovations.

This exclusive license positions Datavault AI (DVLT) at the forefront of AI-driven tokenization and biotech finance, bridging the gap between digital assets and life science commercialization-potentially reshaping how genomic and pharmaceutical data are valued, traded, and monetized worldwide.

Disclaimers: The Private Securities Litigation Reform Act of 1995 provides investors with a safe harbor with regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, assumptions, objectives, goals, and assumptions about future events or performance are not statements of historical fact and may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements, indicating certain actions & quotes; may, could or might occur Understand there is no guarantee past performance is indicative of future results. Investing in micro-cap or growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor's investment may be lost or due to the speculative nature of the companies profiled. TheStreetReports (TSR) is responsible for the production and distribution of this content."TSR" is not operated by a licensed broker, a dealer, or a registered investment advisor. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. "TSR" authors, contributors, or its agents, may be compensated for preparing research, video graphics, podcasts and editorial content. "TSR" has not been compensated to produce content related to "Any Companies" appearing herein. As part of that content, readers, subscribers, and everyone viewing this content are expected to read the full disclaimer in our website.

Media Contact
Company Name: The Street Reports
Contact Person: Editor
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=datavault-ai-nasdaq-dvlt-powers-scilex-holding-nasdaq-sclx-with-exclusive-license-to-tokenize-2-trillion-in-biotech-bonus-stocks-inside]
Country: United States
Website: http://www.thestreetreports.com

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Datavault AI (NASDAQ: DVLT) Powers Scilex Holding (NASDAQ: SCLX) with Exclusive License to Tokenize $2 Trillion in Biotech - Bonus Stocks Inside here

News-ID: 4253634 • Views:

More Releases from ABNewswire

Great Yarmouth Serviced Accommodation: QF Living Signs Pavilion Sands Apartment in Gorleston-on-Sea
Great Yarmouth Serviced Accommodation: QF Living Signs Pavilion Sands Apartment …
Two-bedroom coastal apartment near the seafront and River Yare, designed for leisure and business stays. Image: https://www.abnewswire.com/upload/2026/02/d6ed430595914579b21c5f71bc16191e.jpg Great Yarmouth, Norfolk - QF Living, a locally operated Great Yarmouth serviced accommodation provider, has expanded its portfolio with the signing of Pavilion Sands Apartment in Gorleston-on-Sea [https://qfliving.com/listing/pavilion-sands-apartment/], a newly launched two-bedroom coastal apartment located close to the seafront and near the mouth of the River Yare. The addition strengthens QF Living's offering for leisure guests,
New Book
New Book "Cybercracy" by Pepe Kamel Unmasks the Invisible Architecture of Modern …
Pepe Kamel's new book, Cybercracy: From Citizen to User, exposes the invisible digital architecture shifting power from individuals to technical systems. The book audits modern infrastructure-from submarine cables to AI-revealing how "terms and conditions" and programmable money are replacing constitutional rights. Kamel provides a strategic roadmap for reclaiming individual sovereignty through intellectual, material, and financial independence in an automated world. AUSTIN, TEXAS - In a world where digital convenience often masks
Tampa's Fusion Medispa Reports Emscuplt Neo Technology Breakthrough Results with Advanced Body Contouring Technology
Tampa's Fusion Medispa Reports Emscuplt Neo Technology Breakthrough Results with …
Fusion Medispa in Tampa offers advanced body contouring, laser hair removal, and comprehensive aesthetic treatments. With 20+ years of experience, the facility delivers results through evidence-based technologies. Body contouring has reached a new milestone in Tampa as Fusion Medispa [https://www.google.com/maps/place/Fusion+Medispa/@28.091793,-82.57856,17z/data=!3m1!4b1!4m6!3m5!1s0x88c2eab6b9922de9:0x1ad40973fa28767b!8m2!3d28.091793!4d-82.57856!16s%2Fg%2F1tf7yhy5!5m1!1e3?entry=ttu&g_ep=EgoyMDI2MDIxMS4wIKXMDSoASAFQAw%3D%3D] continues to deliver transformative Emsculpt Neo results using advanced non-invasive technology. With over 20 years of experience and more than 70,000 treatments completed, the award-winning facility has positioned itself as a
Yachiyo City Osteopathic Clinic Expands Patient Centered Musculoskeletal Care in Chiba Prefecture
Yachiyo City Osteopathic Clinic Expands Patient Centered Musculoskeletal Care in …
Image: https://www.abnewswire.com/upload/2026/02/67a7c8f893cfb00a06e172e87242f594.jpg Yachiyo, Chiba Prefecture - February 23, 2026 - A growing demand for non-invasive, hands-on treatment options has led to expanded services at Yachiyo City Osteopathic Clinic [https://miura-seikotsuin.jp/], providing residents with comprehensive care focused on pain relief, mobility restoration, and overall physical wellness. Located in Yachiyo, the clinic serves patients from across the region, including neighboring areas near Funabashi and Chiba. With a strong emphasis on personalized treatment plans, the clinic

All 5 Releases


More Releases for NASDAQ:

Blasting Off with Space Sector Companies Including: Ascent Solar Technologies: N …
With the Artemis II Manned Moon Mission Set to Launch Could $ASTI be on the Same Rocket Ride Trajectory as $ASTS and $LUNR? Image: https://www.globalnewslines.com/uploads/2026/02/13b5a8ac7a0c22438ac498119e1b3551.jpg $ASTI is Positioned to Serve the $1 Trillion Global Space Economy Projected by 2040 . Ascent Solar Technologies, Inc. (NASDAQ: ASTI) is backed by 40 years of R&D, 15 years of manufacturing experience, numerous awards, and a comprehensive IP and patent portfolio. ASTI is a leading provider of
Peraso (NASDAQ: PRSO) Pushes Back on Mobix Labs (NASDAQ: MOBX) Takeover Bid, Val …
Peraso Inc. (NASDAQ: PRSO), a leading innovator in mmWave wireless solutions, has officially acknowledged receipt of an unsolicited, non-binding acquisition proposal from Mobix Labs, Inc. (NASDAQ: MOBX). The offer proposes a stock-for-stock exchange that values Peraso at approximately $1.20 per share, representing a 20% premium over its 30-day average closing price. However, Peraso is contesting several key points made in Mobix's June 26 press release. Financials Mischaracterized, Says Peraso Peraso rebuffed Mobix's
ZenaTech's (Nasdaq: ZENA) Nasdaq Listing: A Launchpad for Growth and Innovation
On October 1, ZenaTech (Nasdaq: ZENA) made its debut on the Nasdaq, a pivotal milestone for the company specializing in AI-driven drone solutions and enterprise SaaS (software-as-a-service) applications. As businesses increasingly seek innovative ways to streamline operations and boost productivity, ZenaTech stands ready to meet these demands with its advanced AI drone solutions and comprehensive software applications. Under the leadership of CEO Dr. Shaun Passley, ZenaTech aims to leverage its
Investors Alert: EMCORE (NASDAQ: EMKR), AGBA Group (NASDAQ: AGBA), Peraso Inc. ( …
EMCORE Corporation (NASDAQ: EMKR) saw its shares soar today following a major announcement from Mobix Labs (NASDAQ: MOBX). Mobix Labs, a leader in advanced wireless solutions for military and defense, has submitted a proposal to acquire all outstanding shares of EMCORE for $3.80 per share in cash, positioning itself as a key player in the aerospace and defense sectors. This move could provide immediate value to shareholders, making it an
Market Movers to Watch: Black Diamond (Nasdaq: BDTX), Peraso Inc. (NASDAQ: PRSO) …
Pre-market trading is heating up as Black Diamond Therapeutics, Inc. (Nasdaq: BDTX) surges on positive Phase 2 data for its cancer treatment BDTX-1535. Peraso Inc. (NASDAQ: PRSO) continues its expansion into the Asian markets and a major military contract. Kaival Brands (NASDAQ: KAVL) saw its stock surge in early trading today on merger announcement. Other stocks to watch include Banzai International Inc. (NASDAQ: BNZI), which saw a 97.51% rally after
Lawsuit filed for Investors who lost money with Alphabet Inc. (NASDAQ: GOOG, NAS …
An investor, who purchased shares of Alphabet Inc. (NASDAQ: GOOG, NASDAQ: GOOGL), filed a lawsuit over alleged violations of Federal Securities Laws by Alphabet Inc. in connection with certain allegedly false and misleading statements. Investors who purchased shares of Alphabet Inc. (NASDAQ: GOOG, NASDAQ: GOOGL), have certain options and for certain investors are short and strict deadlines running. Deadline: May 15, 2023. NASDAQ: GOOG, NASDAQ: GOOGL investors should contact the Shareholders